NDC 11695-1597 - Dextrose

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 11695-1597
Package NDCs from labels: 11695-1597-3
Manufacturer: Covetrus | Nova-Tech, Inc.
Effective date: 2023-12-27
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Dextrose Solution 50%	Covetrus \| Nova-Tech, Inc.	2023-12-27	OTC ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
11695-1597-3	Dextrose	500 mL in 1 BOTTLE, PLASTIC	INJECTION, SOLUTION	500		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
11695-1597	DEXTROSE INJECTION, SOLUTION [COVETRUS]	4	1 package rows	20231228_8955a87b-f159-4cda-95b6-e866f30567de.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 7 · 123 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Potassium Chloride in Dextrose	POTASSIUM CHLORIDE AND DEXTROSE MONOHYDRATE	Baxter Healthcare Company	45de5402-5e61-4bbd-8bbc-5e3392c9920e	2019-07-15	Warnings, Adverse reactions	Exact identifier unii: LX22YL083G
Potassium Chloride in Dextrose and Sodium Chloride	POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE	Baxter Healthcare Company	c553fed1-3de5-4826-8eff-633b5923bf0b	2019-02-21	Warnings, Adverse reactions	Exact identifier unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	051f7347-5a76-4664-8fe2-e61b3dfcb0e4	2014-08-27		Exact identifier unii: LX22YL083G

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.